Valneva is a specialty vaccine company focused on the development, manufacturing and commercialization of prophylactic vaccines for infectious diseases. Our strategy is based on an integrated business model that has allowed us to build a portfolio of differentiated clinical and pre-clinical assets as well as a robust commercial portfolio.
Upcoming Events
June 7, 2023
Jefferies Healthcare Conference
June 12, 2023
Goldman Sachs Annual Global Healthcare Conference
Q1 2023 Financial Results
Valneva Reports First Quarter 2023 Financial Results and Provides Corporate Updates
View MoreContact
Investor Relations Team
Campus Bio-Ouest6, Rue Alain Bombard
44800 Saint-Herblain, France T: +33 2 28 07 37 10 investors@valneva.com